Pacifica Partners’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.97K | Hold |
150
| – | – | ﹤0.01% | 378 |
|
|
2025
Q1 | $4.28K | Hold |
150
| – | – | ﹤0.01% | 391 |
|
|
2024
Q4 | $5.2K | Hold |
150
| – | – | ﹤0.01% | 366 |
|
|
2024
Q3 | $6.01K | Hold |
150
| – | – | ﹤0.01% | 383 |
|
|
2024
Q2 | $6.84K | Hold |
150
| – | – | ﹤0.01% | 387 |
|
|
2024
Q1 | $6.58K | Hold |
150
| – | – | ﹤0.01% | 392 |
|
|
2023
Q4 | $7.5K | Hold |
150
| – | – | ﹤0.01% | 401 |
|
|
2023
Q3 | $7.03K | Hold |
150
| – | – | ﹤0.01% | 384 |
|
|
2023
Q2 | $6.33K | Hold |
150
| – | – | ﹤0.01% | 345 |
|
|
2023
Q1 | $5.57K | Hold |
150
| – | – | ﹤0.01% | 373 |
|
|
2022
Q4 | $5.58K | Hold |
150
| – | – | ﹤0.01% | 341 |
|
|
2022
Q3 | $6K | Hold |
150
| – | – | ﹤0.01% | 349 |
|
|
2022
Q2 | $6K | Hold |
150
| – | – | ﹤0.01% | 351 |
|
|
2022
Q1 | $5K | Hold |
150
| – | – | ﹤0.01% | 373 |
|
|
2021
Q4 | $5K | Hold |
150
| – | – | ﹤0.01% | 363 |
|
|
2021
Q3 | $5K | Hold |
150
| – | – | ﹤0.01% | 360 |
|
|
2021
Q2 | $6K | Hold |
150
| – | – | ﹤0.01% | 336 |
|
|
2021
Q1 | $7K | Hold |
150
| – | – | 0.01% | 297 |
|
|
2020
Q4 | $9K | Hold |
150
| – | – | 0.01% | 258 |
|
|
2020
Q3 | $7K | Hold |
150
| – | – | 0.01% | 252 |
|
|
2020
Q2 | $9K | Hold |
150
| – | – | 0.01% | 239 |
|
|
2020
Q1 | $8K | Hold |
150
| – | – | 0.01% | 251 |
|
|
2019
Q4 | $9K | Buy |
+150
| New | +$9K | 0.01% | 245 |
|